Tag: Prescription Drugs
ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight
Sustained reduction seen in body weight versus placebo for adults aged 18 to 75 with overweight or obesity, without diabetes
Quality Improvement Initiative Ups Adherence to Medical Therapy for Heart Failure
Defect-free quadruple medication therapy significantly improved at discharge, 30 days in patients with heart failure with reduced ejection fraction
Few Adolescents With Obesity Prescribed Obesity Medications
0.5 percent with obesity were prescribed an obesity medication in 2023; 83 percent of prescriptions received by teens with severe obesity
Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM
Greater reduction in urinary albumin-to-creatinine ratio seen for combination versus either agent alone
Dapagliflozin Beneficial for Improving MASH Without Worsening Fibrosis
Dapagliflozin results in more patients with improved or resolved MASH without worsening of fibrosis, improved fibrosis without worsening of MASH
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI
Risk for major adverse cardiac and cerebrovascular events lower compared with aspirin monotherapy for patients who undergo PCI and discontinue DAPT
ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer
Better event-free survival outcomes seen for durvalumab plus FLOT versus FLOT alone in phase 3 randomized trial
Initiation of HIV PrEP in Young Adults Rose in Recent Years
PrEP dispensing and initiation have increased but PrEP persistence has decreased
ASCO: Elinzanetant Cuts Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer
Lamivudine Improves Visual Acuity in Center-Involved Diabetic Macular Edema
Best corrected visual acuity improved 9.8 letters with lamivudine after four weeks, decreased 1.8 letters with placebo